Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NKTX Nkarta

未开盘 11-18 16:00:00 EST

2.49

-0.04

-1.58%

盘后2.51

+0.02+0.80%

19:32 EST

最高2.62	最低2.45	成交量171.93万
今开2.54	昨收2.53	日振幅6.72%
总市值1.76亿	流通市值1.09亿	总股本7,057万
成交额432.48万	换手率3.92%	流通股本4,389万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NKTX","market":"US","secType":"STK","nameCN":"Nkarta","latestPrice":2.49,"timestamp":1731963600000,"preClose":2.53,"halted":0,"volume":1719287,"hourTrading":{"tag":"盘后","latestPrice":2.51,"preClose":2.49,"latestTime":"19:32 EST","volume":4306,"amount":10737.64,"timestamp":1731976336236},"delay":0,"floatShares":43886072,"shares":70568754,"eps":-1.791781,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.04,"latestTime":"11-18 16:00:00 EST","open":2.54,"high":2.62,"low":2.45,"amount":4324807.4769559,"amplitude":0.067194,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.791781,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1594353600000,"adjPreClose":2.53,"preHourTrading":{"tag":"盘前","latestPrice":2.52,"preClose":2.53,"latestTime":"09:28 EST","volume":5959,"amount":15409.9608902,"timestamp":1731940080012},"postHourTrading":{"tag":"盘后","latestPrice":2.51,"preClose":2.49,"latestTime":"19:32 EST","volume":4306,"amount":10737.64,"timestamp":1731976336236},"volumeRatio":1.639047,"impliedVol":1.1976,"impliedVolPercentile":0.3665},"requestUrl":"/m/hq/s/NKTX/wiki","defaultTab":"wiki","newsList":[{"id":"2483382722","title":"Nkarta, Inc.盘中异动 股价大跌5.33%报2.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483382722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483382722?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:29","pubTimestamp":1731605397,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时29分，Nkarta, Inc.股票出现异动，股价快速跳水5.33%。截至发稿，该股报2.76美元/股，成交量46.7047万股，换手率0.66%，振幅5.15%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115012958971a69d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115012958971a69d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX","BK4505","BK4139"],"gpt_icon":0},{"id":"2483583302","title":"Nkarta, Inc.2024财年第三财季实现净利润-28.34百万美元，同比减少10.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483583302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483583302?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:00","pubTimestamp":1731513633,"startTime":"0","endTime":"0","summary":"11月14日，Nkarta, Inc.公布财报，公告显示公司2024财年第三财季净利润为-28.34百万美元，同比减少10.49%；其中营业收入为0.00美元，每股基本收益为-0.39美元。从资产负债表来看，Nkarta, Inc.总负债1.01亿美元，其中短期债务6.76百万美元，资产负债比为5.27，流动比率为0.13。机构评级：截至2024年11月14日，当前有7家机构对Nkarta, Inc.目标价做出预测，其中目标均价为16.86美元，其中最低目标价为11.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114000115a2348677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114000115a2348677&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTX"],"gpt_icon":0},{"id":"2482738415","title":"Nkarta, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738415?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:38","pubTimestamp":1731335934,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时38分，Nkarta, Inc.股票出现异动，股价快速上涨5.02%。截至发稿，该股报3.35美元/股，成交量3.543万股，换手率0.05%，振幅3.45%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223855971a5b40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223855971a5b40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2481110174","title":"Nkarta, Inc.盘中异动 早盘快速跳水5.06%报3.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481110174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481110174?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:33","pubTimestamp":1731076414,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时33分，Nkarta, Inc.股票出现异动，股价快速下跌5.06%。截至发稿，该股报3.10美元/股，成交量3.6701万股，换手率0.05%，振幅4.59%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822333498e4178c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822333498e4178c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2481158588","title":"Nkarta, Inc.盘中异动 下午盘急速下跌5.07%报3.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481158588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481158588?lang=zh_cn&edition=full","pubTime":"2024-11-08 03:21","pubTimestamp":1731007289,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日03时21分，Nkarta, Inc.股票出现波动，股价急速跳水5.07%。截至发稿，该股报3.18美元/股，成交量35.098万股，换手率0.50%，振幅5.67%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108032129abaafdc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108032129abaafdc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"gpt_icon":0},{"id":"2481617727","title":"Nkarta Inc    预计每股亏损 36 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481617727","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481617727?lang=zh_cn&edition=full","pubTime":"2024-11-06 13:26","pubTimestamp":1730870802,"startTime":"0","endTime":"0","summary":"   * Nkarta Inc    预计在11月7日公布截至2024年9月30日的财报时，季度收入将没有变化(预计)    *    * LSEG 的分析师平均预计 Nkarta Inc 每股亏损 36 美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 9 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Nkarta Inc 的 12 个月目标价中位数为 17.00 美元，高于其上次收盘价 3.25 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Nkarta Inc    预计每股亏损 36 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NKTX"],"gpt_icon":0},{"id":"2480587640","title":"Nkarta, Inc.盘中异动 早盘快速上涨5.02%报3.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480587640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480587640?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:19","pubTimestamp":1730733599,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时19分，Nkarta, Inc.股票出现波动，股价快速上涨5.02%。截至发稿，该股报3.35美元/股，成交量12.1845万股，换手率0.17%，振幅5.80%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232000a2155f07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232000a2155f07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2480088481","title":"Nkarta, Inc.盘中异动 早盘股价大涨5.19%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480088481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480088481?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:01","pubTimestamp":1730469717,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日22时01分，Nkarta, Inc.股票出现异动，股价快速上涨5.19%。截至发稿，该股报3.24美元/股，成交量6.4678万股，换手率0.09%，振幅4.22%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101220157a2096efe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101220157a2096efe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2479033764","title":"Nkarta, Inc.盘中异动 急速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479033764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479033764?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:58","pubTimestamp":1730383107,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时58分，Nkarta, Inc.股票出现波动，股价急速下跌5.07%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为2.41%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Aditxt, Inc.、Evogene Ltd.、Palisade Bio, Inc.较为活跃，换手率分别为215.34%、214.82%、153.84%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为45.05%、39.30%、28.17%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215827a2023aca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215827a2023aca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2479478134","title":"Nkarta, Inc.盘中异动 早盘急速上涨5.13%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479478134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479478134?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:16","pubTimestamp":1730297799,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日22时16分，Nkarta, Inc.股票出现波动，股价快速拉升5.13%。截至发稿，该股报3.59美元/股，成交量10.0631万股，换手率0.14%，振幅6.03%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103022163998e3f701&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103022163998e3f701&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2479523836","title":"Nkarta, Inc.盘中异动 股价大跌5.07%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479523836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479523836?lang=zh_cn&edition=full","pubTime":"2024-10-29 23:43","pubTimestamp":1730216602,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日23时43分，Nkarta, Inc.股票出现波动，股价急速跳水5.07%。截至发稿，该股报3.28美元/股，成交量39.0585万股，换手率0.55%，振幅4.91%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029234322a1f5f64f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029234322a1f5f64f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","NKTX","BK4139"],"gpt_icon":0},{"id":"2478662211","title":"Nkarta, Inc.盘中异动 快速跳水5.43%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478662211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478662211?lang=zh_cn&edition=full","pubTime":"2024-10-25 03:34","pubTimestamp":1729798477,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日03时34分，Nkarta, Inc.股票出现波动，股价急速跳水5.43%。截至发稿，该股报3.66美元/股，成交量42.2745万股，换手率0.60%，振幅5.81%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025033437971a2224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025033437971a2224&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2477532074","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.29%报3.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477532074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477532074?lang=zh_cn&edition=full","pubTime":"2024-10-23 23:05","pubTimestamp":1729695948,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日23时05分，Nkarta, Inc.股票出现波动，股价急速下挫5.29%。截至发稿，该股报3.94美元/股，成交量10.0879万股，换手率0.14%，振幅3.81%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为1.20%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023230549a1e432c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023230549a1e432c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2477586582","title":"Nkarta, Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477586582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477586582?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:32","pubTimestamp":1729517535,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时32分，Nkarta, Inc.股票出现波动，股价大幅上涨5.16%。截至发稿，该股报4.48美元/股，成交量4.0016万股，换手率0.06%，振幅3.99%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213215a1e24949&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021213215a1e24949&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2476213920","title":"Nkarta, Inc.盘中异动 下午盘股价大涨5.25%报4.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476213920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476213920?lang=zh_cn&edition=full","pubTime":"2024-10-19 03:23","pubTimestamp":1729279420,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日03时23分，Nkarta, Inc.股票出现波动，股价快速上涨5.25%。截至发稿，该股报4.21美元/股，成交量34.2152万股，换手率0.48%，振幅5.63%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019032340ab6b37f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019032340ab6b37f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2476941507","title":"Nkarta, Inc.盘中异动 快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476941507","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476941507?lang=zh_cn&edition=full","pubTime":"2024-10-17 00:48","pubTimestamp":1729097291,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日00时48分，Nkarta, Inc.股票出现异动，股价急速上涨5.04%。截至发稿，该股报4.17美元/股，成交量20.8953万股，换手率0.30%，振幅7.46%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017004812971a0ad8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017004812971a0ad8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"gpt_icon":0},{"id":"2475936046","title":"Nkarta, Inc.盘中异动 股价大涨5.14%报4.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475936046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475936046?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:02","pubTimestamp":1728914555,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时02分，Nkarta, Inc.股票出现异动，股价大幅上涨5.14%。截至发稿，该股报4.09美元/股，成交量8.3812万股，换手率0.12%，振幅5.14%。Nkarta, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101422023598e3c495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101422023598e3c495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NKTX","BK4505"],"gpt_icon":0},{"id":"2474746263","title":"Nkarta, Inc.盘中异动 早盘股价大跌5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474746263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474746263?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:35","pubTimestamp":1728567309,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日21时35分，Nkarta, Inc.股票出现异动，股价大幅下挫5.58%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Aditxt, Inc.、Tempest Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为120.26%、111.68%、99.71%，振幅较大的相关个股有Tempest Therapeutics, Inc.、Inhibikase Therapeutics, Inc.、Klotho Neurosciences, Inc.，振幅分别为12.59%、11.11%、8.66%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010213509a1dfb6f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010213509a1dfb6f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0},{"id":"2473771105","title":"Nkarta, Inc.盘中异动 大幅下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473771105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473771105?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:35","pubTimestamp":1728308120,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时35分，Nkarta, Inc.股票出现波动，股价快速下跌5.10%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Scholar Rock Holding Corporation、Nutriband Inc C/Wts 、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Aditxt, Inc.、Phio Pharmaceuticals Corp.、Elevai Labs, Inc.较为活跃，换手率分别为578.88%、48.97%、11.82%，振幅较大的相关个股有Scholar Rock Holding Corporation、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Ibio, Inc.，振幅分别为31.81%、18.44%、11.42%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213521a1deac64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241007213521a1deac64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","NKTX"],"gpt_icon":0},{"id":"2472950223","title":"Nkarta, Inc.盘中异动 早盘快速上涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472950223","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472950223?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:48","pubTimestamp":1728049687,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时48分，Nkarta, Inc.股票出现波动，股价大幅上涨5.38%。Nkarta, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Aditxt, Inc.、Sagimet Biosciences Inc. - Series A、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为8196.43%、31.68%、25.76%，振幅较大的相关个股有Aditxt, Inc.、Sagimet Biosciences Inc. - Series A、Theriva Biologics, Inc.，振幅分别为47.42%、24.51%、12.29%。Nkarta, Inc.公司简介：Nkarta Inc 是一家生物制药公司，致力于开发工程自然杀伤细胞来治疗癌症和自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042148079719e62c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042148079719e62c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","NKTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nkartatx.com","stockEarnings":[{"period":"1week","weight":-0.2655},{"period":"1month","weight":-0.4155},{"period":"3month","weight":-0.5127},{"period":"6month","weight":-0.6417},{"period":"1year","weight":-0.046},{"period":"ytd","weight":-0.6227}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nkarta, Inc.于2015年7月在特拉华州成立。该公司是一家私人生物制药公司，致力于开发工程化的自然杀伤（NK）细胞来对抗癌症。该公司致力于利用NK细胞的天然强大功能来识别和杀死异常细胞，并募集适应性免疫效应子以产生特异性和持久性的反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.112423},{"month":2,"riseRate":0.5,"avgChangeRate":0.066988},{"month":3,"riseRate":0.25,"avgChangeRate":-0.082272},{"month":4,"riseRate":0.5,"avgChangeRate":0.150196},{"month":5,"riseRate":0.25,"avgChangeRate":-0.125785},{"month":6,"riseRate":0.25,"avgChangeRate":-0.12509},{"month":7,"riseRate":1,"avgChangeRate":0.058112},{"month":8,"riseRate":0.4,"avgChangeRate":-0.07656},{"month":9,"riseRate":0.2,"avgChangeRate":-0.069244},{"month":10,"riseRate":0.2,"avgChangeRate":-0.076206},{"month":11,"riseRate":0.6,"avgChangeRate":-0.006605},{"month":12,"riseRate":0.5,"avgChangeRate":0.50486}],"exchange":"NASDAQ","name":"Nkarta","nameEN":"Nkarta"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nkarta,NKTX,Nkarta股票,Nkarta股票老虎,Nkarta股票老虎国际,Nkarta行情,Nkarta股票行情,Nkarta股价,Nkarta股市,Nkarta股票价格,Nkarta股票交易,Nkarta股票购买,Nkarta股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nkarta(NKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nkarta(NKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}